Pasithea Therapeutics recently issued a press release of a successful clinical trial of a DNA vaccine in a mouse model of MS, reducing disability compared to placebo. The video summarizes the background and data, and at 7:05, there is an interview of professor Lawrence Steinman who is the chairman of Pasithea Therapeutics